Ameriprise
SWAV

Ameriprise’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Ameriprise’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-286,570
Closed -$93.3M – 3970
2024
Q1 		$93.3M Buy
286,570
+209,936
+274% +$51.5M 0.03% 559
2023
Q4 		$14.6M Sell
76,634
-713
-0.9% -$135K ﹤0.01% 1463
2023
Q3 		$15.4M Sell
77,347
-12,429
-14% -$2.94M 0.01% 1390
2023
Q2 		$25.6M Sell
89,776
-15,277
-15% -$4.24M 0.01% 1107
2023
Q1 		$22.8M Buy
105,053
+9,755
+10% +$1.9M 0.01% 1170
2022
Q4 		$19.6M Sell
95,298
-31,280
-25% -$7.91M 0.01% 1238
2022
Q3 		$35.2M Sell
126,578
-2,900
-2% -$737K 0.01% 841
2022
Q2 		$24.8M Buy
129,478
+24,664
+24% +$4.35M 0.01% 1071
2022
Q1 		$21.7M Buy
104,814
+18,071
+21% +$2.98M 0.01% 1291
2021
Q4 		$15.5M Buy
86,743
+1,277
+1% +$252K ﹤0.01% 1611
2021
Q3 		$17.6M Sell
85,466
-3,419
-4% -$671K 0.01% 1373
2021
Q2 		$16.9M Sell
88,885
-8,227
-8% -$1.35M 0.01% 1487
2021
Q1 		$12.7M Sell
97,112
-14,270
-13% -$1.71M ﹤0.01% 1686
2020
Q4 		$11.6M Buy
111,382
+7,199
+7% +$624K ﹤0.01% 1644
2020
Q3 		$7.9M Sell
104,183
-12,510
-11% -$709K ﹤0.01% 1731
2020
Q2 		$5.53M Sell
116,693
-552
-0.5% -$22.7K ﹤0.01% 1996
2020
Q1 		$3.89M Buy
117,245
+32,515
+38% +$1.29M ﹤0.01% 2071
2019
Q4 		$3.72M Buy
84,730
+16,299
+24% +$602K ﹤0.01% 2410
2019
Q3 		$2.05M Buy
68,431
+32,121
+88% +$1.36M ﹤0.01% 2682
2019
Q2 		$2.07M Sell
36,310
-7,719
-18% -$375K ﹤0.01% 2734
2019
Q1 		$1.47M Buy
+44,029
New +$1.46M ﹤0.01% 2880

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ameriprise's SWAV Position: Q2 2024 in Review

Ameriprise sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 286,570 shares — an estimated $93.3M sold.

Ameriprise first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $93.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Ameriprise reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 286,570 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $93.3M.
  • Ameriprise first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Ameriprise's Shockwave Medical, Inc. Common Stock position peaked at $93.3M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.